240 related articles for article (PubMed ID: 21324354)
1. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.
Kalogeras IM
Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354
[TBL] [Abstract][Full Text] [Related]
2. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
3. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
4. Influence of copolymer composition on the phase behavior of solid dispersions.
Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
[TBL] [Abstract][Full Text] [Related]
5. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
[TBL] [Abstract][Full Text] [Related]
7. Estimation of drug solubility in polymers via differential scanning calorimetry and utilization of the fox equation.
Haddadin R; Qian F; Desikan S; Hussain M; Smith RL
Pharm Dev Technol; 2009; 14(1):18-26. PubMed ID: 18825543
[TBL] [Abstract][Full Text] [Related]
8. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
9. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
[TBL] [Abstract][Full Text] [Related]
10. [Crystalline modifications and polymorphism changes during drug manufacture].
Doelker E
Ann Pharm Fr; 2002 May; 60(3):161-76. PubMed ID: 12050595
[TBL] [Abstract][Full Text] [Related]
11. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
[TBL] [Abstract][Full Text] [Related]
12. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
[TBL] [Abstract][Full Text] [Related]
13. Structural modifications of polymethacrylates: impact on thermal behavior and release characteristics of glassy solid solutions.
Claeys B; De Coen R; De Geest BG; de la Rosa VR; Hoogenboom R; Carleer R; Adriaensens P; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1206-14. PubMed ID: 23485474
[TBL] [Abstract][Full Text] [Related]
14. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
Thakore SD; Akhtar J; Jain R; Paudel A; Bansal AK
Mol Pharm; 2021 Aug; 18(8):2835-2866. PubMed ID: 34041914
[TBL] [Abstract][Full Text] [Related]
15. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
[TBL] [Abstract][Full Text] [Related]
16. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
Amharar Y; Curtin V; Gallagher KH; Healy AM
Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
[TBL] [Abstract][Full Text] [Related]
17. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?
Qian F; Huang J; Zhu Q; Haddadin R; Gawel J; Garmise R; Hussain M
Int J Pharm; 2010 Aug; 395(1-2):232-5. PubMed ID: 20562003
[TBL] [Abstract][Full Text] [Related]
18. Dynamic mechanical thermal analysis of hypromellose 2910 free films.
Cespi M; Bonacucina G; Mencarelli G; Casettari L; Palmieri GF
Eur J Pharm Biopharm; 2011 Oct; 79(2):458-63. PubMed ID: 21645616
[TBL] [Abstract][Full Text] [Related]
19. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
20. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone).
Paudel A; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2010 Aug; 7(4):1133-48. PubMed ID: 20524682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]